Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Hydrocephalus Shunts allow excess Cerebrospinal Fluid (CSF) to drain to another area of the body. GlobalData uses proprietary data and analytics to provide a comprehensive report on the hydrocephalus shunts devices market, including market shares of different players within China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the hydrocephalus shunts market in China was Medtronic followed by Aesculap, Natus Medical, Sophysa, Proteses and Spiegelberg.
Hydrocephalus Valves and Hydrocephalus Catheters are covered in this category. Hydrocephalus Valves regulate the flow of CSF out of the brain’s ventricles. Two types of Hydrocephalus Catheters are considered in the market: Antimicrobial Catheters and Standard Catheters.
The value of the hydrocephalus shunts devices market within China was expected to be over $40m in 2023.
For the latest complete market share analysis of hydrocephalus shunts device market in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
